Prof. Dr. med. Erwin Böttinger joined the Wyss Center as Chief Executive Officer (CEO) in April 2023.
Erwin has a longstanding track record in personalized medicine, with emphasis on genomics and digital technologies. Before joining the Wyss Center, he was instrumental in building the Charles Bronfman Institute for Personalized Medicine and the Hasso Plattner Institute for Digital Health at Mount Sinai, at the Icahn School of Medicine at Mount Sinai in New York City, both with a strong translational focus. He was also the principal architect of the Mount Sinai’s BioMe™ Biobank.
Erwin served as founding director of the Digital Health Center at the Hasso Plattner Institute for Digital Engineering and University Potsdam, and as CEO of the Berlin Institute of Health, Berlin, Germany, where he was responsible for BIH’s forward-looking strategy 'Personalized Medicine - Advanced Therapies'.
Research Team